Innovation Pharmaceuticals Inc (IPIX)

[keltoi]

The redacted part is what I choose not to share.

Hi XXX,

From the 10-K
To continue as a going concern, we must secure additional funding to support our current operating plan in
the fiscal quarter ended March 31, 2019. The Company expects to seek to obtain additional funding through
business development activities (i.e. licensing and partnerships) and future equity issuances. There can be
no assurance as to the availability or terms upon which such financing and capital might be available.

The statement reads "in" the March 31 quarter.

As we have stated we are involved in our business development activities while moving forward towards Phase 3. XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
In addition, soon we hope to start up a program we put on hold due to financing needs.



We will keep shareholders posted.






Best wishes,

Leo Ehrlich | CEO |

Innovation Pharmaceuticals Inc.

100 Cummings Center, Suite 151-B Beverly, MA 01915

http://www.iPharminc.com



Email: [e-mail]